BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7206375)

  • 1. Dopamine receptor blocking activity of sulpiride in the canine exocrine pancreas.
    Satoh Y; Satoh H; Honda F
    Jpn J Pharmacol; 1980 Oct; 30(5):689-99. PubMed ID: 7206375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DN-9693, a synthesized phosphodiesterase inhibitor, on pancreatic exocrine secretion in dogs.
    Iwatsuki K; Horiuchi A; Yonekura H; Haruta K; Homma N; Chiba S
    Jpn J Pharmacol; 1989 Jan; 49(1):77-82. PubMed ID: 2470943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol stimulates pancreatic exocrine secretion in the dog.
    Horiuchi A; Iwatsuki K; Yonekura H; Chiba S; Oguchi H
    Pancreas; 1989; 4(2):179-84. PubMed ID: 2755942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human atrial natriuretic polypeptide on pancreatic exocrine secretion in the dog.
    Oguchi H; Iwatsuki K; Horiuchi A; Furuta S; Chiba S
    Biochem Biophys Res Commun; 1987 Jul; 146(2):757-63. PubMed ID: 2956951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of catecholamines and their inhibitors on the isolated canine pancreas. II. Dopamine.
    Bastie MJ; Vaysse N; Brenac B; Pascal JP; Ribet A
    Gastroenterology; 1977 Apr; 72(4 Pt 1):719-23. PubMed ID: 838228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dopamine on exocrine secretion and cyclic nucleotide concentration in the dog pancreas.
    Iijima F; Iwatsuki K; Chiba S
    Eur J Pharmacol; 1983 Sep; 92(3-4):191-7. PubMed ID: 6313394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
    Horiuchi A; Iwatsuki K; Yonekura H; Chiba S
    J Pharmacol Exp Ther; 1989 Aug; 250(2):734-9. PubMed ID: 2474643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bromocriptine on pancreatic secretion in the isolated, blood-perfused pancreas of the dog.
    Iwatsuki K; Iijima F; Chiba S
    Clin Exp Pharmacol Physiol; 1984; 11(3):231-5. PubMed ID: 6744683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopamine on pancreatic secretion in the dog.
    Hashimoto K; Sato S; Takeuchi O
    Br J Pharmacol; 1971 Dec; 43(4):739-46. PubMed ID: 5152026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Adrenoceptor stimulation of exocrine secretion from the rat pancreas.
    Furuta Y; Hashimoto K; Washizaki M
    Br J Pharmacol; 1978 Jan; 62(1):25-9. PubMed ID: 202364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of forskolin on pancreatic exocrine secretion and cyclic nucleotide concentrations of the dog pancreas.
    Iwatsuki K; Horiuchi A; Yamagishi F; Chiba S
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):320-8. PubMed ID: 3036030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in pancreatic exocrine secretion after repeated haloperidol administration.
    Pazo JH; Vaccaro MI; Tumilasci OR; Murer GM; Calvo EL
    J Auton Nerv Syst; 1989 Dec; 28(3):189-92. PubMed ID: 2576428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide enhances bethanechol-induced pancreatic exocrine secretion of the dog.
    Yamagishi F; Haruta K; Homma N; Iwatsuki K; Chiba S
    Clin Exp Pharmacol Physiol; 1985; 12(6):565-71. PubMed ID: 2871953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hydergine on pancreatic exocrine secretion in the isolated, blood-perfused pancreas of the dog.
    Iwatsuki K; Iijima F; Chiba S
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):328-34. PubMed ID: 6838289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a synthesized phosphodiesterase inhibitor, ZSY-27, on pancreatic exocrine secretion of the dog.
    Iwatsuki K; Yamagishi F; Chiba S
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):487-94. PubMed ID: 3757312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucagon on pancreatic secretion in the dog.
    Iwatsuki K; Ono H; Hashimoto K
    Clin Exp Pharmacol Physiol; 1976; 3(1):59-65. PubMed ID: 971553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect stimulation of pancreatic exocrine secretion by neurotensin in anaesthetized dogs.
    Iwatsuki K; Horiuchi A; Ren LM; Chiba S
    Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):475-81. PubMed ID: 1914248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of central dopamine on basal pancreatic secretion in conscious rats.
    Masuda M; Kanai S; Miyasaka K
    Am J Physiol; 1998 Jan; 274(1):G29-34. PubMed ID: 9458770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of synthesized phosphodiesterase inhibitors, DM 9278 and HWA 285, on pancreatic exocrine secretion of the dog.
    Yamagishi F; Homma N; Haruta K; Iwatsuki K; Chiba S
    Jpn J Pharmacol; 1985 Oct; 39(2):131-6. PubMed ID: 3841375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amines and the rat exocrine pancreas: (1). Effects of receptor blockers on turnover of L-dopa.
    Mori J; Satoh Y; Hashimoto M; Honda F
    Jpn J Pharmacol; 1979 Dec; 29(6):899-911. PubMed ID: 44324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.